Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Pragmatus could this be PTSC's answer to replacing Alliacense and leckrones
Strictly speaking, wouldn't it fall to PDS to change? This would be a lot easier if Leckrone is replaced, but there would still be paperwork and who knows what the Moore/TPL agreement contains?!
Share
New Message
Please login to post a reply